| Financial Year |
March 31 2023 |
| Monetary Funds |
498,260,114.89 |
| Held-for-trading Financial Assets |
651,727,427.40 |
| Notes Receivable |
145,091,347.71 |
| Accounts Receivable |
1,643,551,586.28 |
| Advances to Suppliers |
177,986,255.86 |
| Other Receivables |
36,178,092.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,304,263,051.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
63,175,806.31 |
| Total Current Assets |
7,183,222,708.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
871,490,769.24 |
| Under-construction Projects |
699,912,621.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
187,635,369.63 |
| R&D expenses |
13,685,744.57 |
| Goodwill |
5,454,268.07 |
| Long-Term Deferred and Prepaid Expenses |
149,225,907.40 |
| Deferred Income Tax Assets |
75,756,175.88 |
| Other Non-Current Assets |
352,605,561.05 |
| Sub-Total of Non-Current Assets |
2,626,660,382.72 |
| Total Assets |
9,809,883,091.06 |
| Short-Term Loans |
100,088,888.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,026,996,765.71 |
| Accounts Payable |
1,753,847,034.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
114,335,813.71 |
| Taxes Payable |
10,586,376.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,473,125.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
274,982,515.91 |
| Other Current Liabilities |
122,992,990.90 |
| Sub-Total of Current Liabilities |
5,421,324,918.43 |
| Long-term Loans |
862,001,171.43 |
| Bonds Payable |
774,414,233.27 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,000,381.35 |
| Other Non-Current Liabilities |
4,049,604.00 |
| Sub-Total of Non-Current Liabilities |
1,834,886,632.73 |
| Total Liabilities |
7,256,211,551.16 |
| Paid-In Capital(Or Share Stock) |
88,304,362.00 |
| Capital Surplus |
1,611,875,411.80 |
| Surplus Reserve |
44,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
612,174,613.43 |
| Minority Stockholder's Interest |
1,233,214.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,552,438,325.49 |
| Owner's Equity（Stockholder's Equity） |
2,553,671,539.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,809,883,091.06 |
